Dental supply maker Patterson Companies Inc (NASDAQ:PDCO) announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.
What Happened: The company disclosed the sale process as part of its second-quarter financial report.
Earnings were mixed, “given the challenging end market environment,” said Patterson CEO Don Zurbay.
Patterson posted second-quarter 2025 net sales of $1.67 billion. That’s up 1.3% year-over-year. Wall Street expected a net sales of $1.65 billion. Internal sales increased just 0.6%.
Here’s a breakdown of the dental business:
As for Patterson’s animal health segment:
The company reported adjusted EPS of 47 cents. That’s down from 50 cents a year ago. It missed the consensus of 49 cents.
GAAP and adjusted earnings were also negatively impacted by the Change Healthcare cyber attack.
Patterson “took dedicated cost management actions” and “made targeted investments in complementary businesses,” according to Zurbay.
Outlook: Patterson expects fiscal year 2025 adjusted EPS Of $2.25-$2.35 compared to the consensus of $2.32 and prior guidance of $2.33-$2.43.
Price Action: Patterson stock is up 6.54% at $23.31 during the premarket session at last check Thursday.
Read Next:
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。